Search
-
Two Years On: Lessons From Covid Times
Two years into the unprecedented upheavals instigated by a global pandemic, it feels like a good moment to take stock and think about what we have learned during this dramatic period.
-
Leveraging Real-World Evidence to Drive Pricing & Access
The importance of Multiple Data Source Integration and Value Attribution in Multi-Component Disease Management.
-
Oncology in the Time of COVID
The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.
-
The Path to Techquity
Ipsos partnered with the HLTH Foundation to shine a light on existing health tech-related inequities in the US and identify opportunities for the industry to address techquity gaps.
-
The Future of Point of Care & Rapid Testing
How have the Point of Care (PoC) and rapid testing markets evolved over the past two years? What are the key challenges, unmet needs and opportunities for companies working in POC & rapid testing today?
-
Ipsos Update - March 2022
Opinion polling, the year ahead in Brazil, gender inequality in Japan, and the future of ageing are all featured topics in this month’s round-up of research and thinking from Ipsos teams around the world.
-
What Worries the World - February 2022
The global public’s top 5 concerning issues remain unchanged, with Covid-19 still top. But inflation now ranks 6th with almost one in four (23%) worldwide now saying it is a worry in their country.
-
A Year in Oncology: A review of 2021 drug approvals in US, Europe and Japan
Whilst the global COVID-19 pandemic continued throughout 2021, new oncology drug and indication approvals maintained momentum across the US, Europe and Japan. These included continued roll-out and label expansions of Immuno-Oncology (I-O) therapies, along with treatments approved in Japan ahead of other global regions.
-
Conquering Complexity: The ongoing revolution in oncology biomarker testing
The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalised medicine now well-entrenched in the treatment paradigm.
-
Public Opinion on the COVID-19 pandemic
In an uncertain world, data matters. Ipsos experts share the latest research and analysis related to the coronavirus pandemic.